News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Relypsa, Inc. to Present Phase 3 Data in Late-Breaking Poster Session at ASN Kidney Week 2013 Annual Meeting in Atlanta, GA


10/21/2013 7:18:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Relypsa, Inc., a clinical-stage biopharmaceutical company, today announced that the American Society of Nephrology (ASN) has accepted its abstract for the late-breaking clinical trial poster session of the ASN Kidney Week 2013 Annual Meeting in Atlanta, GA.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES